Clinical trial / 2017
Daily supplementation with NRPT safely increased whole blood NAD+ levels in a dose-dependent manner in healthy older adults.
A randomized, double-blind, placebo-controlled study evaluated the safety and efficacy of daily supplementation with NRPT (nicotinamide riboside and pterostilbene) for 8 weeks in 120 healthy adults aged 60 to 80. Participants received placebo, a recommended dose (NRPT 1X), or a double dose (NRPT 2X). After 4 weeks, NAD+ levels increased by approximately 40% in the NRPT 1X group and approximately 90% in the NRPT 2X group compared to placebo and baseline, with increases sustained across the 8-week trial. NAD+ levels did not increase in the placebo group, and no serious adverse events were reported.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 120 healthy adults between the ages of 60 and 80 years
- What was measured
- Safety and whole blood NAD+ concentrations
THE PAPER
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.
Dellinger RW, Santos SR, Morris M, Evans M, Alminana D, Guarente L, Marcotulli E. NPJ Aging Mech Dis, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.